Sanders Capital, LLC Astrazeneca PLC Transaction History
Sanders Capital, LLC
- $81.3 Billion
- Q3 2025
A detailed history of Sanders Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sanders Capital, LLC holds 14,058,682 shares of AZN stock, worth $1.26 Billion. This represents 1.33% of its overall portfolio holdings.
Number of Shares
14,058,682
Previous 14,526,862
3.22%
Holding current value
$1.26 Billion
Previous $1.02 Billion
6.25%
% of portfolio
1.33%
Previous 1.37%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...